NCT04308941

Brief Summary

The goal of this research is to determine the reproducibility of measurements of intraocular pressure (IOP) when a scleral lens is on the eye. The PROSE device (PD) is a specialized scleral lens that is filled with preservative-free saline and then applied to the eye in order to treat a variety of ocular conditions. The fit of the PROSE device is optimized to land gently on the conjunctival tissue overlying the sclera while completely vaulting the cornea and limbus without touch. Because the PROSE device vaults and therefore covers the cornea, measuring IOP during PROSE wear is challenging as traditional techniques rely on corneal contact (i.e. Goldmann tonometry, iCare, pneumatonometry, etc.). Measuring IOP before insertion and after removal of the PROSE device likely does not correspond to the true IOP when the PROSE device is actively on the eye. This is a prospective study of the reproducibility of three non-traditional means of IOP measurements: scleral tonopen, scleral pneumatonometry, and transpalpebral Diaton tonometer. Evaluating these means of measurements may be important for future studies investigating the effect of PROSE wear on intraocular pressure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 12, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 16, 2020

Completed
28 days until next milestone

Study Start

First participant enrolled

April 13, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 27, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 27, 2021

Completed
2.5 years until next milestone

Results Posted

Study results publicly available

November 9, 2023

Completed
Last Updated

November 9, 2023

Status Verified

October 1, 2023

Enrollment Period

1 year

First QC Date

March 12, 2020

Results QC Date

July 20, 2022

Last Update Submit

October 18, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • The Goal of This Research is to Determine the Reproducibility of Measurements of Intraocular Pressure (IOP) When a Scleral Lens is on the Eye.

    Intraocular pressure will be measured using one of three different tonometers. The reproducibility of measurements on each device will be studied.

    patient will participate for 1 hour

Study Arms (3)

Scleral Tonopen

ACTIVE COMPARATOR

The first 10 subjects will be randomly chosen for the first cohort (scleral TonoPen)

Diagnostic Test: Intraocular pressure

Scleral Pneumatonometer

ACTIVE COMPARATOR

The second 10 subjects will be randomly chosen for the second cohort (scleral pneumatonometry)

Diagnostic Test: Intraocular pressure

Diaton

ACTIVE COMPARATOR

The third 10 subjects will be randomly chosen for the third cohort (Diaton).

Diagnostic Test: Intraocular pressure

Interventions

Intraocular pressureDIAGNOSTIC_TEST

The intraocular pressure will be measured using one of three devices

DiatonScleral PneumatonometerScleral Tonopen

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Written Informed Consent has been obtained prior to any study-related procedures taking place
  • Written documentation has been obtained in accordance with the relevant county and local privacy requirements, where applicable
  • Male or female, 18 years of age and older prior to the initial visit
  • Is an established wearer of PROSE in both eyes; without fenestrations or channels; with diameter equal to or greater than 18.0 mm
  • Upon examination by the investigator, there is adequate exposure of the sclera as required for IOP measurements with the planned device
  • In the opinion of the investigator, the subject has the ability to follow study instructions
  • In the opinion of the investigator, the subject has the ability to complete all study procedures and visits

You may not qualify if:

  • Is aphakic (i.e., missing their natural lens inside the eye)
  • Is currently participating in any other type of eye-related clinical or research study
  • Is pregnant or nursing as reported by the subject
  • Less than 18 years of age
  • Has a condition or is in a situation which, in the investigator's opinion, may put the subject at significant risk, may confound study outcomes, or may significantly interfere with the subject's participation in the study
  • Has had previous ocular surgery within the past 12 weeks
  • Has a diagnosis of glaucoma, glaucoma suspect, ocular hypertension or prior glaucoma surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BostonSight

Needham, Massachusetts, 02494, United States

Location

MeSH Terms

Interventions

Intraocular Pressure

Intervention Hierarchy (Ancestors)

Ocular Physiological Phenomena

Results Point of Contact

Title
Dr. Daniel Brocks
Organization
BostonSight

Study Officials

  • Daniel Brocks, MD

    Boston Sight

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Subjects will be enrolled in each cohort sequentially there is no masking of procedures
Purpose
DIAGNOSTIC
Intervention Model
SEQUENTIAL
Model Details: The first 10 subjects will be randomly chosen for the first cohort (scleral TonoPen), the second 10 subjects will be randomly chosen for the second cohort (scleral pneumatonometry), and the third 10 subjects will be randomly chosen for the third cohort (Diaton).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Invesigator

Study Record Dates

First Submitted

March 12, 2020

First Posted

March 16, 2020

Study Start

April 13, 2020

Primary Completion

April 27, 2021

Study Completion

April 27, 2021

Last Updated

November 9, 2023

Results First Posted

November 9, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

We do not anticipate the need to share but will publish findings

Locations